HoxD4 inhibitors belong to a class of chemical compounds that target and modulate the activity of the HoxD4 gene. Hox genes, including HoxD4, are a subset of the homeobox gene family, which play critical roles in regulating the development and organization of body structures during embryogenesis. HoxD4 specifically is involved in the patterning of the anterior-posterior axis, as well as in the segmentation of various tissues and organs. Inhibition of HoxD4 can disrupt its gene expression and alter the downstream effects on cellular differentiation, tissue formation, and spatial identity in developing organisms. The precise control of these genes is vital for maintaining the intricate coordination required for the formation of body structures.
HoxD4 inhibitors, at a molecular level, function by interfering with the transcriptional activity of the HoxD4 gene. These inhibitors can act through different mechanisms, such as direct binding to the HoxD4 gene's promoter regions, thereby preventing the recruitment of transcription factors, or by affecting epigenetic modulators that regulate HoxD4 expression. These molecular interactions can lead to changes in chromatin accessibility or modifications to histone proteins, ultimately influencing the transcriptional landscape. Additionally, some HoxD4 inhibitors may interact with signaling pathways that indirectly control the expression of HoxD4, highlighting the complexity of its regulation. These inhibitors are valuable tools for studying gene regulation and developmental biology, particularly in understanding how precise control of Hox genes is critical for proper morphogenesis and cellular identity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Could inhibit histone deacetylases, affecting chromatin structure and HoxD4 transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Could inhibit histone deacetylases, potentially affecting HoxD4 transcription. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
May inhibit DNA methyltransferases, affecting the methylation status of the HoxD4 gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Might affect the methylation status of DNA, influencing HoxD4 gene expression. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Could inhibit ROCK, potentially affecting cellular processes that may influence HoxD4 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Might inhibit MEK, potentially affecting signaling pathways that regulate HoxD4 expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Could inhibit TGF-β signaling, possibly influencing pathways that regulate HoxD4 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
May inhibit JNK, potentially affecting signaling pathways that influence HoxD4 expression. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
Might inhibit GSK-3, potentially affecting Wnt signaling and HoxD4 expression. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
Could disrupt p53-MDM2 interaction, potentially affecting pathways influencing HoxD4 expression. | ||||||